Synergy Pharmaceuticals Overview
- Status
-
Acquired/Merged
- Employees
-
313
- Latest Deal Type
-
M&A
- Financing Rounds
-
8
- Investments
-
2
Synergy Pharmaceuticals General Information
Description
Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.
Contact Information
Website
www.synergypharma.comCorporate Office
- 420 Lexington Avenue
- Suite 2012
- New York, NY 10170
- United States
Corporate Office
- 420 Lexington Avenue
- Suite 2012
- New York, NY 10170
- United States
Synergy Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Synergy Pharmaceuticals Comparisons
Industry
Financing
Details
Synergy Pharmaceuticals Competitors (21)
One of Synergy Pharmaceuticals’s 21 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Phathom Pharmaceuticals | Formerly VC-backed | Florham Park, NJ | ||||
| Evoke Pharma | Formerly VC-backed | Solana Beach, CA | ||||
| OrphoMed | Venture Capital-Backed | San Francisco, CA | ||||
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA |
Synergy Pharmaceuticals Patents
Synergy Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3009814-A1 | Formulations and methods for treating ulcerative colitis | Inactive | 11-Jan-2016 | ||
| WO-2017123634-A1 | Formulations and methods for treating ulcerative colitis | Inactive | 11-Jan-2016 | ||
| CA-3001727-A1 | Compositions and method for the treatment and detection of colon cancer | Inactive | 18-Nov-2015 | ||
| WO-2017087879-A2 | Compositions and method for the treatment and detection of colon cancer | Inactive | 18-Nov-2015 | ||
| WO-2017087879-A3 | Compositions and method for the treatment and detection of colon cancer | Inactive | 18-Nov-2015 | A61K9/5153 |
Synergy Pharmaceuticals Signals
Synergy Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Synergy Pharmaceuticals Acquisitions (2)
Synergy Pharmaceuticals’s most recent deal was a Merger/Acquisition with Callisto Pharmaceuticals for . The deal was made on 17-Jan-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Callisto Pharmaceuticals | 17-Jan-2013 | Merger/Acquisition | Drug Discovery | ||
| Pawfect Foods | 21-Jul-2008 | Merger/Acquisition | Internet Retail |
Synergy Pharmaceuticals FAQs
-
Where is Synergy Pharmaceuticals headquartered?
Synergy Pharmaceuticals is headquartered in New York, NY.
-
What is the size of Synergy Pharmaceuticals?
Synergy Pharmaceuticals has 313 total employees.
-
What industry is Synergy Pharmaceuticals in?
Synergy Pharmaceuticals’s primary industry is Other Healthcare Services.
-
Is Synergy Pharmaceuticals a private or public company?
Synergy Pharmaceuticals is a Private company.
-
What is the current valuation of Synergy Pharmaceuticals?
The current valuation of Synergy Pharmaceuticals is .
-
What is Synergy Pharmaceuticals’s current revenue?
The current revenue for Synergy Pharmaceuticals is .
-
How much funding has Synergy Pharmaceuticals raised over time?
Synergy Pharmaceuticals has raised $438M.
-
Who are Synergy Pharmaceuticals’s investors?
Aisling Capital, Callisto Pharmaceuticals, Great Point Partners, and Pawfect Foods have invested in Synergy Pharmaceuticals.
-
Who are Synergy Pharmaceuticals’s competitors?
Inovio Pharmaceuticals, Phathom Pharmaceuticals, Evoke Pharma, OrphoMed, and BioMarin Pharmaceutical are some of the 21 competitors of Synergy Pharmaceuticals.
-
When was Synergy Pharmaceuticals acquired?
Synergy Pharmaceuticals was acquired on 06-Mar-2019.
-
Who acquired Synergy Pharmaceuticals?
Synergy Pharmaceuticals was acquired by Bausch Health Companies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process